SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
This Quarter Return
-2.38%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
AUM
$85.4M
AUM Growth
Cap. Flow
+$85.4M
Cap. Flow %
100%
Top 10 Hldgs %
94.55%
Holding
13
New
13
Increased
Reduced
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VNDA icon
1
Vanda Pharmaceuticals
VNDA
$279M
$17.9M 20.93% +1,918,929 New +$17.9M
CTIC
2
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$13.2M 15.42% +10,698,618 New +$13.2M
SCLN
3
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$10.8M 12.67% +1,175,574 New +$10.8M
TBRA
4
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$8.38M 9.81% +833,377 New +$8.38M
SGNT
5
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$7.36M 8.63% +462,824 New +$7.36M
PTX
6
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$7.33M 8.59% +2,484,649 New +$7.33M
SAVA icon
7
Cassava Sciences
SAVA
$110M
$6.26M 7.33% +3,575,000 New +$6.26M
FMI
8
DELISTED
Foundation Medicine, Inc.
FMI
$3.64M 4.27% +173,049 New +$3.64M
VCEL icon
9
Vericel Corp
VCEL
$1.83B
$3.55M 4.16% +1,376,887 New +$3.55M
ENTA icon
10
Enanta Pharmaceuticals
ENTA
$180M
$2.35M 2.75% +71,147 New +$2.35M
DSCI
11
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$2.32M 2.72% +507,799 New +$2.32M
CUTR
12
DELISTED
Cutera, Inc.
CUTR
$1.28M 1.5% +100,000 New +$1.28M
SCTL
13
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.05M 1.23% +116,901 New +$1.05M